Quisel John D exercised Options for 36,000 Disc Medicine shares at $1.01 per share on 2026-09-15. The transaction left him with 262,064 shares and 150,120 derivative securities, giving investors separate figures for his common-stock and derivative-security holdings after the option exercise.
Key Highlights
- Quisel John D held 262,064 Disc Medicine shares after the transaction.
- His resulting derivative-securities balance stood at 150,120.
- The exercise represented about 13.7% of his resulting shares holding and about 19.3% of his prior derivative-securities holding.
Disc Medicine (NASDAQ: IRON) CEO Quisel John D exercised options for 36,000 shares at $1.01 per share on 15 September 2026. The transaction covered both Disc Medicine shares and derivative securities.
Option Exercise Details
The transaction left Quisel John D with 262,064 Disc Medicine shares. The exercise represented about 13.7% of his resulting shares holding. The same transaction involved 36,000 derivative securities, with 150,120 derivative securities remaining afterward. That amount represented about 19.3% of his prior derivative-securities holding. Code M identifies the transaction as an option exercise rather than an open-market purchase or sale. The reported ownership figures separate the common-share balance from the derivative-securities balance.
FAQs
Q: How many Disc Medicine shares did Quisel John D acquire through options?
A: Quisel John D exercised options for 36,000 Disc Medicine shares. The exercise price was $1.01 per share on 15 September 2026.
Q: What was Quisel John D’s Disc Medicine ownership after the transaction?
A: Quisel John D owned 262,064 Disc Medicine shares after the option exercise. The transaction represented about 13.7% of his resulting shares holding.
Q: How many derivative securities did Quisel John D hold afterward?
A: Quisel John D held 150,120 derivative securities after the transaction. The exercise represented about 19.3% of his prior derivative-securities holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.